Next-Generation Endocrine Therapies for Breast Cancer.
Publication
, Journal Article
McDonnell, DP; Wardell, SE; Chang, C-Y; Norris, JD
Published in: J Clin Oncol
April 20, 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
April 20, 2021
Volume
39
Issue
12
Start / End Page
1383 / 1388
Location
United States
Related Subject Headings
- Selective Estrogen Receptor Modulators
- Oncology & Carcinogenesis
- Mutation
- Humans
- Female
- Estrogen Receptor alpha
- Breast Neoplasms
- Antineoplastic Agents, Hormonal
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
McDonnell, D. P., Wardell, S. E., Chang, C.-Y., & Norris, J. D. (2021). Next-Generation Endocrine Therapies for Breast Cancer. J Clin Oncol, 39(12), 1383–1388. https://doi.org/10.1200/JCO.20.03565
McDonnell, Donald P., Suzanne E. Wardell, Ching-Yi Chang, and John D. Norris. “Next-Generation Endocrine Therapies for Breast Cancer.” J Clin Oncol 39, no. 12 (April 20, 2021): 1383–88. https://doi.org/10.1200/JCO.20.03565.
McDonnell DP, Wardell SE, Chang C-Y, Norris JD. Next-Generation Endocrine Therapies for Breast Cancer. J Clin Oncol. 2021 Apr 20;39(12):1383–8.
McDonnell, Donald P., et al. “Next-Generation Endocrine Therapies for Breast Cancer.” J Clin Oncol, vol. 39, no. 12, Apr. 2021, pp. 1383–88. Pubmed, doi:10.1200/JCO.20.03565.
McDonnell DP, Wardell SE, Chang C-Y, Norris JD. Next-Generation Endocrine Therapies for Breast Cancer. J Clin Oncol. 2021 Apr 20;39(12):1383–1388.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
April 20, 2021
Volume
39
Issue
12
Start / End Page
1383 / 1388
Location
United States
Related Subject Headings
- Selective Estrogen Receptor Modulators
- Oncology & Carcinogenesis
- Mutation
- Humans
- Female
- Estrogen Receptor alpha
- Breast Neoplasms
- Antineoplastic Agents, Hormonal
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis